Skip to main content
HOSPITALScience City Rd+91 97234 31544
AEC CLINICNaranpura+91 70460 02566
WhatsApp Hospital 11:00 AM – 8:00 PM | Clinic 8:30 AM – 10:30 AM

Balaji Horizon Women's Hospital

Last clinically reviewed by Dr. Priyadatt Patel on 8 June 2026

IVF · Polycystic ovary syndrome

IVF in polycystic ovary syndrome — high response, careful protocols

Patients with polycystic ovary syndrome (PCOS) are at the opposite end of the spectrum from poor responders. The challenge is not getting enough follicles; it is getting them safely. Hyperresponse, ovarian hyperstimulation syndrome (OHSS), and atypical embryology all need to be planned for. This page describes how IVF in PCOS is conducted to deliver good cumulative success with low complication rates.

Why PCOS-IVF needs its own approach

Three features make PCOS-IVF distinctive:

  • High antral follicle count — large pool of follicles ready to respond to FSH
  • Sensitivity to gonadotropins — patients often need lower starting doses than apparent ovarian reserve would suggest
  • Elevated OHSS risk — both immediate (during the cycle) and late (if pregnancy occurs after fresh transfer)

Pre-cycle optimisation

  • Glycaemic and weight assessment — metformin where indicated, structured lifestyle support
  • Vitamin D, thyroid, prolactin, androgen panel
  • Endometrial assessment if there is a history of irregular shedding
  • Realistic conversation about expected yield (often high, sometimes very high)

Protocol of choice

The GnRH antagonist protocol with low-dose gonadotropin start is the standard. It allows the option of a GnRH agonist trigger instead of hCG, which substantially reduces OHSS risk while still triggering oocyte maturation. The agonist trigger combined with a planned freeze-all approach is among the safest paths in high-AMH patients.

Long agonist protocols are now used only selectively in PCOS because of their higher OHSS profile.

Monitoring

  • Frequent ultrasound and oestradiol monitoring
  • Adjusting dose down (or pausing) when oestradiol rises rapidly
  • Counting follicles on each scan and pre-empting OHSS rather than reacting to it
  • Coasting (pausing gonadotropins while continuing antagonist) where indicated

Triggering and OHSS prevention

  • GnRH agonist trigger as default in high-risk patients
  • Cabergoline in the post-trigger period
  • Freeze-all strategy in patients at substantial risk, with elective frozen embryo transfer in a subsequent cycle
  • Dual trigger (agonist plus low-dose hCG) in selected lower-risk patients
  • Albumin or hydroxyethyl starch — no longer routine, used selectively per current evidence

Embryology in PCOS

Oocyte yield is typically high; however, fertilisation and embryo development rates can be slightly lower per oocyte. Quality control is the focus — high-quality blastocyst selection, often with PGT-A in selected patients, and single embryo transfer to avoid the additive OHSS risk of multiple pregnancy.

Frozen embryo transfer

After a freeze-all, transfer is performed in a subsequent cycle — either a natural cycle, modified natural, or hormone-replaced cycle, depending on the patient’s cycle pattern. PCOS patients often need hormone-replaced protocols because of unpredictable ovulation, but natural-cycle transfer is preferred where ovulation can be reliably timed.

Long-term metabolic health

IVF in PCOS is also an opportunity to address long-term cardiometabolic risk. The pre-conception and post-treatment conversation covers insulin resistance, weight, blood pressure, lipids, and the elevated long-term type 2 diabetes risk. Pregnancy after PCOS-IVF carries higher rates of gestational diabetes and hypertensive disorders; the antenatal pathway is intensified accordingly.

Guidelines we follow on this topic

  • International PCOS Guideline 2023
  • ESHRE Ovarian Stimulation Guideline
  • ASRM committee opinion on OHSS
  • NICE fertility guidance

PCOS patients are at higher risk of OHSS. GnRH antagonist protocols with agonist trigger and freeze-all strategy reduce OHSS risk significantly compared with traditional long protocols.

— ESHRE Guideline on Ovarian Stimulation, 2019 (updated 2023)

CONTINUE READING

IVF with PCOS

FeatureApproach
Strong ovarian responseAntagonist protocol
OHSS riskGnRH-agonist trigger, freeze-all
Egg qualityIndividualised support

Explore the IVF Programme

IVF in PCOS is one part of the broader IVF and fertility programme. The main IVF pillar covers individualised protocols, success counselling, and long-term reproductive planning.

Your fertility team
Dr Priyadatt Patel, fertility and reproductive surgeon, Ahmedabad

Dr Priyadatt Patel
Lead — Fertility, Endometriosis & Reproductive Surgery

Dr Patel leads fertility care at Balaji Horizon, integrating reproductive surgery and IVF into a single plan — ethical, evidence-based and individualised, with realistic expectations and no overpromising of success.

Dr Shreya Iyengar Patel, fertility and reproductive medicine, Ahmedabad

Dr Shreya Iyengar Patel
Fertility & Reproductive Medicine
Talk to our fertility team

Individualised IVF and fertility planning with honest, evidence-based counselling — and realistic expectations from the very first consultation.

Book a consultation

★★★★★5.0 · 282 Verified Google Reviews

Dr. Priyadatt Patel

Senior Gynecologist · Advanced Laparoscopic Surgeon · IVF and Endometriosis Programme Lead

MS OBGyn · Pregnancy Care · Advanced Gynaecological Ultrasound · Fertility Preservation

ESHRE / ESGE / AAGL / ASRM guideline-aligned practice. 3D Karl Storz precision technique. Fertility-preservation-first philosophy. Evidence-based decisions, honest counselling, long-term outcomes orientation.

Endometriosis
Superficial to deep infiltrating, fertility-preserving excision
IVF & Fertility
Individualised protocols, ART Level 2 lab, transparent outcomes
Advanced Laparoscopy
3D Karl Storz precision, nerve-sparing technique
Pregnancy Care
Antenatal care, high-risk pregnancy, advanced ultrasound
Balaji Horizon Women Hospital
Science City Road, Ahmedabad 380060
Mon–Sat 11:00–20:00 · +91 97234 31544
Balaji Women Clinic (AEC)
Naranpura, Ahmedabad
Mon–Sat 08:30–10:30 · +91 70460 02566
Bureau Veritas ISO 9001 UKAS accreditation 0008 — Balaji Horizon Women's Hospital

Internationally Accredited · State Registered

ISO 9001:2015 Quality Management System — UKAS Accredited Certification by Bureau Veritas

Certificate IND.25.899/QM/U · Valid until 02 September 2028 · Independently verify at certcheck.ukas.com

Permanently registered under Gujarat Clinical Establishments Act, 2021 · Reg. No. CEA/AHD/262/2025 · Single Speciality Hospital · 15 Beds

Operated by Balaji Women’s Clinic · Trading as Balaji Horizon Women’s Hospital

CALL BOOK ON WHATSAPP